| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 653743 | 67531 | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67531/67531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67531/67531_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A.U. | 2006-02-02 | 1 | 1 | 1 | 2006-02-02 | 2006-02-02 | 1 | 2015-07-06 | View Edit Delete | ||||||||||||
| 652611 | 07391001 | REVLIMID 5 MG CAPSULAS DURAS | REVLIMID 5 MG CAPSULAS DURAS, 21 cápsulas | 5 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391001/07391001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391001/07391001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663224 | View Edit Delete | |||||||||||
| 652629 | 07391002 | REVLIMID 10 MG CAPSULAS DURAS | REVLIMID 10 MG CAPSULAS DURAS, 21 cápsulas | 10 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391002/07391002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391002/07391002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663222 | View Edit Delete | |||||||||||
| 652645 | 07391003 | REVLIMID 15 MG CAPSULAS DURAS | REVLIMID 15 MG CAPSULAS DURAS, 21 cápsulas | 15 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391003/07391003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391003/07391003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663223 | View Edit Delete | |||||||||||
| 652652 | 07391004 | REVLIMID 25 MG CAPSULAS DURAS | REVLIMID 25 MG CAPSULAS DURAS, 21 cápsulas | 25 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391004/07391004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391004/07391004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663225 | View Edit Delete | |||||||||||
| 652751 | 06363006 | SPRYCEL 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SPRYCEL 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 70 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06363006/06363006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06363006/06363006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-11-29 | 1 | 1 | 1 | 2006-11-29 | 2012-01-17 | 1 | 2013-01-03 | 656420 | View Edit Delete | |||||||||||
| 652769 | 06363005 | SPRYCEL 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SPRYCEL 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06363005/06363005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06363005/06363005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-11-29 | 1 | 1 | 1 | 2006-11-29 | 2012-01-17 | 1 | 2013-01-03 | 656419 | View Edit Delete | |||||||||||
| 654637 | 06343003 | BARACLUDE 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BARACLUDE 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 0,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06343003/06343003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06343003/06343003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-07-11 | 1 | 1 | 1 | 2006-07-11 | 2006-07-11 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 654638 | 06343004 | BARACLUDE 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BARACLUDE 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06343004/06343004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06343004/06343004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-07-11 | 1 | 1 | 1 | 2006-07-11 | 2006-07-11 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 654269 | 59785 | OPIREN 30 mg CAPSULAS | OPIREN 30 mg CAPSULAS , 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59785/59785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59785/59785_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | TAKEDA FARMACEUTICA ESPANA S.A. | 1993-06-01 | 1 | 1 | 1 | 1993-06-01 | 1998-01-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 653572 | 67460 | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 14 comprimidos | 20 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67460/67460_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67460/67460_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2006-01-16 | 1 | 1 | 1 | 2006-01-16 | 2006-01-16 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 653573 | 67460 | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67460/67460_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67460/67460_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2006-01-16 | 1 | 1 | 1 | 2006-01-16 | 2006-01-16 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 653574 | 67460 | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67460/67460_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67460/67460_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2006-01-16 | 1 | 1 | 1 | 2006-01-16 | 2006-01-16 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 654576 | 67878 | DERCUTANE 40 mg CAPSULAS BLANDAS | DERCUTANE 40 mg CAPSULAS BLANDAS, 50 cápsulas | 40 mg | 5 | 50 | 43 | 50 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/67878/67878_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67878/67878_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 39651 | INDUSTRIAL FARMACEUTICA CANTABRIA S.A. | 2006-06-15 | 1 | 1 | 1 | 2006-06-15 | 2006-06-15 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 654124 | 67672 | OLMETEC PLUS 20 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OLMETEC PLUS 20 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67672/67672_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67672/67672_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2006-03-31 | 1 | 1 | 1 | 2006-03-31 | 2006-03-31 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 654139 | 67678 | OPENVAS PLUS 20 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 20 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67678/67678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67678/67678_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2006-04-03 | 1 | 1 | 1 | 2006-04-03 | 2006-04-03 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 654140 | 67679 | OLMETEC PLUS 20 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OLMETEC PLUS 20 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67679/67679_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67679/67679_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2006-03-31 | 1 | 1 | 1 | 2006-03-31 | 2006-03-31 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 654141 | 67680 | OPENVAS PLUS 20 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 20 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67680/67680_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67680/67680_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2006-04-03 | 1 | 1 | 1 | 2006-04-03 | 2006-04-03 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 652699 | 67237 | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG , 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67237/67237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67237/67237_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2005-11-21 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 652700 | 67237 | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG , 120 comprimidos | 2 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67237/67237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67237/67237_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2005-11-21 | 1 | 2011-06-16 | View Edit Delete |
Page 102 of 1036, showing 20 records out of 20704 total, starting on record 2021, ending on 2040